|
119th CONGRESS
2d Session |
Expressing support for the designation of March 3, 2026, as “National Triple-Negative Breast Cancer Day”.
Mr. Morelle (for himself, Mr. Bacon, Mr. Tonko, Mr. Gottheimer, and Ms. Norton) submitted the following resolution; which was referred to the Committee on Oversight and Government Reform
Expressing support for the designation of March 3, 2026, as “National Triple-Negative Breast Cancer Day”.
Whereas triple-negative breast cancer was recognized as a distinct type of cancer in 2006;
Whereas triple-negative breast cancer disproportionately affects young women, Black and Hispanic women, and those with BRCA gene mutations;
Whereas triple-negative breast cancers are estrogen receptor-negative, progesterone receptor-negative, and HER2-negative, making them distinct from other breast cancers;
Whereas 10 to 15 percent of all breast cancer diagnoses are designated as triple-negative;
Whereas triple-negative breast cancer can be more aggressive and more likely to spread and recur;
Whereas triple-negative breast cancer accounts for around 25 percent of all deaths from breast cancer in the United States; and
Whereas March 3, 2026, would be an appropriate date to designate as “National Triple-Negative Breast Cancer Day”: Now, therefore, be it
Resolved, That the House of Representatives supports the designation of “National Triple-Negative Breast Cancer Day” to create awareness of the devastating effect of these cancers on families in the United States and the need for strong action to eradicate triple-negative breast cancer.